Alibaba Health Information Technology Limited (TWY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Alibaba Health Information Technology Limited (TWY) has a cash flow conversion efficiency ratio of 0.017x as of September 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€252.02 Million) by net assets (€14.92 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Alibaba Health Information Technology Limited - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Alibaba Health Information Technology Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Alibaba Health Information Technology Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alibaba Health Information Technology Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Akbank TAS
IS:AKBNK
|
-0.212x |
|
Sanan Optoelectronics Co Ltd
SHG:600703
|
0.020x |
|
Chubu Electric Power Company Incorporated
F:0C2
|
N/A |
|
GAIL (INDIA) GDR/6 IR 10
F:GQI
|
N/A |
|
Trade Desk Inc
NASDAQ:TTD
|
0.125x |
|
Qantas Airways Ltd
AU:QAN
|
1.251x |
|
Getlink SE
PA:GET
|
0.135x |
|
OGE Energy Corporation
NYSE:OGE
|
0.077x |
Annual Cash Flow Conversion Efficiency for Alibaba Health Information Technology Limited (2017–2025)
The table below shows the annual cash flow conversion efficiency of Alibaba Health Information Technology Limited from 2017 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | €16.31 Billion | €1.40 Billion | 0.086x | +14.97% |
| 2024-03-31 | €14.52 Billion | €1.08 Billion | 0.074x | +340.64% |
| 2023-03-31 | €15.15 Billion | €255.69 Million | 0.017x | -44.02% |
| 2022-03-31 | €14.07 Billion | €424.36 Million | 0.030x | -57.33% |
| 2021-03-31 | €14.28 Billion | €1.01 Billion | 0.071x | -36.99% |
| 2020-03-31 | €5.20 Billion | €583.62 Million | 0.112x | -22.54% |
| 2019-03-31 | €2.74 Billion | €396.37 Million | 0.145x | +619.99% |
| 2018-03-31 | €2.52 Billion | €-70.27 Million | -0.028x | +86.22% |
| 2017-03-31 | €1.12 Billion | €-226.25 Million | -0.202x | -- |
About Alibaba Health Information Technology Limited
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family pl… Read more